Human tumour xenografts have been widely used for the purpose of assessing the responsiveness of human tumours to chemotherapeutic agents (Giovanella et al., 1974; Kopper & Steel, 1975; Povisen & Jacobsen 1975; Fodstad et al., 1977; Osieka et al., 1977; Ovejera et al., 1978; Giovanella et al., 1983) , and for evaluating the antineoplastic activity of new anticancer drugs (Bellet et al., 1979; Venditti, 1981) . So far largely xenografts growing subcutaneously in athymic or immunosuppressed mice have been used. However, the procedures involved are expensive and time consuming and efforts have therefore been made to develop simpler and more rapid in vivo methods.
During the last few years Bogden et al. (1978, 1979, 1981) have introduced a new procedure involving the implantation of small, solid pieces of human tumours under the renal capsule of normal. conventional mice and evaluation 6 days later of the graft response to treatment. This "6-day subrenal capsule (SRC) assay" in immunocompetent mice has been used on fresh surgical explants to assess the response of individual human tumours to chemotherapeutic agents , and to evaluate the anti-tumour activity of new experimental drugs (Cobb et al., 1983) .
The SRC assay has several favourable features. It is fairly rapid and relatively inexpensive. However, before the assay can be accepted as a routine procedure several questions must be answered.
Thus, it is not clear whether the observed increases in the size of the subrenal grafts are actually due to proliferation of tumour cells and whether the grafts retain their characteristics during growth under the renal capsule. In fact, it has been reported (Seltzer et al., 1983) that the observed increase in implant size resulted from inflammation and oedema rather than from tumour growth, and Edelstein et al. (1983) found that most or part of the subrenal grafts on Day 6 was replaced by granulation tissue due to immune-mediated inflammation. In their study no mitoses were observed and the residual tumour cells showed signs of degeneration and necrosis.
For methodological studies of the subrenal capsule assay, human tumour xenografts, serially transplanted in athymic, nude mice, possess several advantages as a source of tumour tissue. Such xenografts represent a constant and readily available source of material that can be produced in desired quantities. Importantly, in contrast to patients' biopsies they permit the repetition of experiments on the same fresh, previously untreated tumour cells. We have studied the growth properties of such subrenal grafts in a previous paper (Aamdal et al., 1984b) . The application and usefulness of subrenal grafts for the purpose of chemosensitivity measurements have been considered elsewhere (Aamdal et al., 1983a (Aamdal et al., , 1984c (Aamdal et al., , 1984d and will be treated in more detail in a forthcoming publication.
In S.c. implantation of tumour tissues in athymic, nude mice was carried out as described by Fodstad et al. (1980) .
Evaluation of tutmour size
In the studies of the subrenal grafts the size of the tumour was measured immediately after implantation by using a stereoscopic microscope, fitted with an ocular micrometer, calibrated in ocular units (OMU) (1OOMU=1 mm). Two perpendicular diameters were measured. At the end of the experiment, usually after 6 days, the animals were sacrifised by halothan, the kidney was removed and the grafts were again measured in situ. The difference in mean tumour diameter during the growth period was calculated.
The size of the s.c. tumours in athymic nude mice was measured twice weekly by calipers (2 vertical diameters) as described by Fodstad et al. (1980) .
All implantations and evaluations of grafts were carried out by one of the authors (S.A.).
Immunosuppression
In some cases the mice were immunosuppressed by administration of 200mg kg-cyclophosphamide (Farmos Group, Turku, Finland) Estimation of mitotic activity In several sections from each xenograft all mitoses present were recorded. In each case at least 1,000 tumour cells were counted.
Immunohistochemical studies Carcino-embryonic antigen (CEA) was visualized in tissue sections fixed in ice cold 96% ethanol. The sections were incubated with tetramethylrhodamine isothiocyanate (TRITC)-labeled rabbit IgG anti-CEA conjugate (Rognum et al., 1980) , and subsequently, to enhance the red signal, incubated with TRITC-labeled swine anti-rabbit IgG. The observations were done in a Leitz Orthoplan fluorescence microscope equipped with an Osram HBO 200 W lamp. Narrow-band excitation and selective filtration of fluorescence colours were obtained with a Ploem-type epiilluminator.
Human cells were distinguished from mouse cells by an immunohistochemical method specific for human cells. Formalin-fixed tissue sections were incubated with rabbit anti-human IgG and subsequently with horse-radish peroxidase (HRP)-labeled swine anti-rabbit IgG obtained from DAKO-Immunoglobulins A/S Copenhagen, Denmark. The anti-human antibody was produced in rabbits by repeated s.c. injections of 2 x 107 human leukocytes, dissolved the first time in Freund's incomplete adjuvant and later in NaCI. Neighbouring section were always stained with Hematoxylin and Eosin.
Electron microscopy Tissues for electron microscopy were fixed in McDowell's solution (McDowell & Trump, 1976) , postfixed in osmium tetroxide, dehydrated in graded alcohols and embedded in an Epon-Araldite mixture. Semi-thin sections stained with toluidine blue were used for light-microscopic examination. Ultra-thin sections were cut with diamond knives, mounted on naked copper grids, stained with uranyl acetate and lead citrate and examined in the transmission electron microscope.
Tissue for scanning electron microscopy were critical-point dried, mounted on metal stubs and sputter-coated with gold.
Titration of anti-melanoma antibodies The content of anti-melanoma antibody in the serum of mice after tumour implantation was measured by an enzyme-linked immunosorbant assay (ELISA), essentially as described by Godal et al. (1983) , using as antigen an extract from a human malignant melanoma, LOX. The antigen was prepared as described by Watson et al. (1975) .
Growth in soft agar
The xenografts were disaggregated to form single cell suspensions, and cloning in soft agar was carried out as described by Tveit & Pihl (1981) .
Results

Growth
All tumours studied, except one, increased in size during the 6-day period after transplantation under the renal capsule. The tumours were usually paler than the surrounding kidney tissue and clearly protruding. In most cases the borderline of the graft was not difficult to discern. A typical macroscopic picture of a subrenal graft is seen in Figure   1 . Figure 1 A subrenal graft, a human malignant melanoma, observed 6 days after transplantation. The mean diameter of the tumour was more than twice that of the grafted piece.
The different tumours grew reproducibly and with individual characteristic rates (Aamdal et al., 1984b) . Typical examples are shown in Figure Table I show significant mitotic activity in all the 8 tumours studied in detail. In fact, in 5/8 cases the mitotic index in the subrenal graft on Day 4 was significantly higher (P<0.03) than in the original xenograft. Also it is seen that in all cases the mitotic index decreased from Day 4 to Day 6. The decrease, possibly due to host immune reactions, was significant (P<0.04) in 7/8 cases.
Histological sections of the subrenal grafts on Day 6 were compared with sections of the corresponding subcutaneous tumours in nude mice. In Figure 3 histological sections are shown of an amelanotic malignant melanoma, grown in nude mice and of the corresponding subrenal tumours on Day 6. Comparison of the sections before and after growth under the renal capsule shows that the subrenal graft contained undifferentiated polygonal cells with abundant cytoplasm, a picture almost identical with that of the original tumour. In a melanotic melanoma, Fontana-Masson staining for melanine was positive both in the original xenograft and after growth for 6 days under the renal capsule (Aamdal et al., 1984c) . (Figure 6 ) and epithelial cells with microvilli in a colon carcinoma (Figure 7) .
Altogether, the results indicate that human tumours transplanted under the renal capsule of Im. (Figure 8 , left panel), indicated that they were inflammatory mouse cells in agreement with previous findings (Edelstein et al., 1983; Aamdal et al., 1984b, c) . The mouse origin of these cells follows from the fact that they were not stained by peroxidase in an immunohistochemical method specific for human cells (not shown). Moreover, lactic dehydrogenase iso-enzyme patterns studied in 11 different tumours showed typical mouse bands in addition to the human bands (data not shown). Faint mouse bands were present also in the xenografts taken from the athymic mice, but these bands were clearly more evident in the subrenal grafts. Since it was assumed by Bogden et al. (1978) that host immune reactions do not become significant until Day 9, it was of interest to follow the time course of appearance of the infiltrating mouse cells. Sections taken on days 2, 3 and 4 of 9 different tumours (5 animals in each group) showed that the infiltration actually started already on Day 4, and became progressively evident with time (not shown). In the case of 15 different tumours the mice were pretreated with the strong immunesuppressive agent cyclophosphamide, CY. In these grafts the small cells failed to appear (Figure 8 , right panel), supporting the view that they represent a cell-mediated response to the human cells.
In mice carrying a melanoma, LOX, a humoral response could also be demonstrated on Day 3 and later ( Figure 9 ). Thus, with an ELISA method employing a rabbit anti-human IgG antibody, it was found that the titre of anti-human antibody was significant already on Day 3 and subsequently increased rapidly. 
Tumourigenic capacity
In order to see whether the tumour cells of the subrenal grafts had retained their malignant character, their ability to form colonies in soft agar and to form tumours in athymic, nude mice was examined. Single cell suspensions of the grafts, taken on Day 6 gave rise to colonies in 7/9 cases studied (not shown).
When the grafts were removed from the kidneys and implanted s.c. in athymic, nude hosts (5 grafts for each tumour tested), out of the 12 different tumours studied altogether 10 grew subcutaneously in the new hosts (6 malignant melanomas, 2 colon carcinomas and 2 sarcomas).
In some instances we had occasion to measure the growth rates of the grafts after re-implantation in athymic mice. It was found that the tumours grew subcutaneously with tumour volume doubling times that were not statistically different from those observed before passage under the renal capsule (P<0.6), indicating that the tumours had retained their characteristic growth rates (data not shown).
Discussion
The use of human tumour xenografts in chemotherapy studies is based on the premise that the transplanted human tumour cells retain important properties, including their chemosensitivity, when growing in the foreign host. Although it can not be excluded that some selection occurs when human tumours are transplanted into athymic, nude mice, there is considerable evidence that upon subsequent serial transplantation they maintain their properties and that they generally reflect rather well the chemosensitivity of the parent tumours (Sordat et al., 1974; Povlsen & Jacobsen, 1975; Houghton & Taylor, 1978; Nowak et al., 1978; Shorthouse et al., 1980; Giuliani et al., 1981; Steel et al., 1983) . For this reason s.c. growth of human tumours in athymic mice has been used as a reference system for other assays of chemosensitivity (Tveit et al., 1982; Aamdal et al., 1983a Aamdal et al., , 1984b . However, evidence that human tumour xenografts transplanted under the renal capsule of immunocompetent mice retain their properties had not been presented.
It was found here, in agreement with our previous findings (Aamdal et al., 1984a (Aamdal et al., , 1984b (Aamdal et al., , 1984c , that a variety of xenografts from different human tumour lines was capable of growing well under the renal capsule of conventional mice, supporting the view that the conditions under the renal capsule of mice are favourable for growth of human tumours (Bogden et al., 1979) .
Several lines of evidence indicated that the subrenal grafts retain morphological and functional characteristics during the assay period of 6 days. Thus, after 6 days under the renal capsule the tumour tissue resembled closely the xenograft of origin. Proliferating tumour tissue with numerous mitoses and little or no necrosis was found. In the instances where characteristic substances could be demonstrated, the tumour tissue retained the ability to produce these substances after growth under the renal capsule.
Of particular significance is our demonstration that the grafted tumour cells had retained their malignant growth potential after 6 days under the kidney capsule. This follows from the demonstration that they were able to form colonies in soft agar and s.c. tumours in athymic mice. The tumours formed had growth rates that were closely similar to those of the original xenografts in athymic mice, indicating that the subrenal tumours present after 6 days were representative of the original s.c. xenografts and were not derived from a selected subpopulation of the tumour cells.
Our results differ from those of Edelstein et al. (1983) and Seltzer et al. (1983) who reported that subrenal human grafts consisted mainly of oedema, inflammatory cells, granulation tissue and necrotic tissue. Part of the discrepancy may be due to the fact that we have used serially transplanted and fairly rapidly growing tumours whereas these authors largely used surgical specimens directly from patients. However, this can hardly account for the whole difference as Edelstein et al. (1983) studied xenografted tissue as well. Obviously, it is essential that only viable tissue is grafted. In our hands the results improved markedly with experience over a period of several years.
The assumption that the cell-mediated responses to a heterograft does not become evident until after the 6-day observation period (Bogden et al., 1979) has not been confirmed (Edelstein et al., 1983; Aamdal et al., 1984b) . The present results show that an immune response may appear already after a few days. Thus, antibodies directed against the transplanted human tissue could be detected already on Day 3, and the infiltration of the graft by host cells was seen already on Day 4.
The infiltration of the subrenal grafts by host cells is a potential source of error in the measurement of the growth of the tumour tissue. However, in a separate study (Aamdal et al., 1984b) where the contribution of the mouse cells to the total graft volume was quantified, it was found that in these tumour lines, the mouse cell infiltration did not significantly affect the growth of the grafts during the 6-day observation period.
The present study is part of an extensive investigation of the 6-day SRC assay and its merits compared to other procedures used for studying the response of human cancer cells to cytostatic drugs. In other papers we have reported that the chemosensitivity of several human tumour xenografts was closely similar when tested in the 6-day SRC and in the athymic, nude mouse model (Aamdal et al., 1983a (Aamdal et al., , 1984c (Aamdal et al., , 1984d . Altogether these results, which recently have been confirmed in more extensive studies (to be published), provide evidence that human tumour lines transplanted under the kidney capsule of conventional mice may be a useful system for screening of new chemotherapeutic drugs. Further studies on specimens obtained directly from patients are required to establish the validity of the 6-day SRC assay as a method for predicting the chemosensitivity of individual human tumours.
